Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens.

Zachor H, Machekano R, Estrella MM, Veldkamp PJ, Zeier MD, Uthman OA, Taljaard JJ, Moosa MR, Nachega JB.

AIDS. 2016 May 15;30(8):1221-8. doi: 10.1097/QAD.0000000000001041.

2.

SAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settings.

Ritchie AV, Ushiro-Lumb I, Edemaga D, Joshi HA, De Ruiter A, Szumilin E, Jendrulek I, McGuire M, Goel N, Sharma PI, Allain JP, Lee HH.

J Clin Microbiol. 2014 Sep;52(9):3377-83. doi: 10.1128/JCM.00593-14. Epub 2014 Jul 16.

3.
4.

Preferred antiretroviral drugs for the next decade of scale up.

Andrieux-Meyer I, Calmy A, Cahn P, Clayden P, Raguin G, Katlama C, Vitoria M, Levin A, Lynch S, Goemaere E, Ford N; Art Sequencing meeting September 22–23, 2011, Geneva, Switzerland.

J Int AIDS Soc. 2012 Sep 18;15(2):17986. doi: 10.7448/IAS.15.2.17986. Review.

5.

Retention and loss to follow-up in antiretroviral treatment programmes in southeast Nigeria.

Onoka CA, Uzochukwu BS, Onwujekwe OE, Chukwuka C, Ilozumba J, Onyedum C, Nwobi EA, Onwasigwe C.

Pathog Glob Health. 2012 Mar;106(1):46-54. doi: 10.1179/2047773211Y.0000000018.

6.

Current practices in laboratory monitoring of HIV infection.

Vajpayee M, Mohan T.

Indian J Med Res. 2011 Dec;134(6):801-22. doi: 10.4103/0971-5916.92627. Review.

7.

Electronic decision protocols for ART patient triaging to expand access to HIV treatment in South Africa: a cross sectional study for development and validation.

Mitchell M, Hedt BL, Eshun-Wilson I, Fraser H, John MA, Menezes C, Grobusch MP, Jackson J, Taljaard J, Lesh N.

Int J Med Inform. 2012 Mar;81(3):166-72. doi: 10.1016/j.ijmedinf.2011.11.003. Epub 2011 Dec 16.

8.

The first decade of antiretroviral therapy in Africa.

Ford N, Calmy A, Mills EJ.

Global Health. 2011 Sep 29;7:33. doi: 10.1186/1744-8603-7-33.

9.

Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries.

Galárraga O, Wirtz VJ, Figueroa-Lara A, Santa-Ana-Tellez Y, Coulibaly I, Viisainen K, Medina-Lara A, Korenromp EL.

Pharmacoeconomics. 2011 Jul;29(7):579-99. doi: 10.2165/11586120-000000000-00000. Review.

10.

Outreach education for integration of HIV/AIDS care, antiretroviral treatment, and tuberculosis care in primary care clinics in South Africa: PALSA PLUS pragmatic cluster randomised trial.

Zwarenstein M, Fairall LR, Lombard C, Mayers P, Bheekie A, English RG, Lewin S, Bachmann MO, Bateman E.

BMJ. 2011 Apr 21;342:d2022. doi: 10.1136/bmj.d2022.

11.

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal.

Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; ANRS 12-06/IMEA 012 Trial Study Group.

J Int AIDS Soc. 2007 Oct 9;9(4):7. doi: 10.1186/1758-2652-9-4-7.

12.

Surgical task shifting in Sub-Saharan Africa.

Chu K, Rosseel P, Gielis P, Ford N.

PLoS Med. 2009 May 19;6(5):e1000078. doi: 10.1371/journal.pmed.1000078. Epub 2009 May 19. No abstract available.

13.

Implementing family-focused HIV care and treatment: the first 2 years' experience of the mother-to-child transmission-plus program in Abidjan, Côte d'Ivoire.

Tonwe-Gold B, Ekouevi DK, Bosse CA, Toure S, Koné M, Becquet R, Leroy V, Toro P, Dabis F, El Sadr WM, Abrams EJ.

Trop Med Int Health. 2009 Feb;14(2):204-12. doi: 10.1111/j.1365-3156.2008.02182.x.

14.

Children and HIV/AIDS: from research to policy and action in resource-limited settings.

Orne-Gliemann J, Becquet R, Ekouevi DK, Leroy V, Perez F, Dabis F.

AIDS. 2008 Apr 23;22(7):797-805. doi: 10.1097/QAD.0b013e3282f4f45a. Review. No abstract available.

15.

Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal.

Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; ANRS 12-06/IMEA 012 Trial Study Group.

MedGenMed. 2007 Oct 9;9(4):7.

16.

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Simon V, Ho DD, Abdool Karim Q.

Lancet. 2006 Aug 5;368(9534):489-504. Review.

17.

Monitoring HIV treatment in developing countries.

Koenig SP, Kuritzkes DR, Hirsch MS, Léandre F, Mukherjee JS, Farmer PE, del Rio C.

BMJ. 2006 Mar 11;332(7541):602-4. Review. No abstract available.

Supplemental Content

Support Center